Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists
US8217046B2 · kind B2 · utility
4Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 2007 |
| Grant date | Jul 10, 2012 |
| Priority date | — |
| Expiry date | Dec 28, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of general formula (I):wherein: These compounds are useful as protease-activated receptor-1 (PAR-1) antagonists, particularly in the treatment of thrombosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.